Rapport Therapeutics, Inc. (RAPP)
(Delayed Data from NSDQ)
$14.43 USD
+0.39 (2.78%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $14.38 -0.05 (-0.35%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Rapport Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RAPP 14.43 +0.39(2.78%)
Will RAPP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RAPP based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for RAPP
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Citizens JMP
Citizens JMP pharmaceuticals analysts hold analyst/industry conference call
RAPP: JMP Securities Reiterates Market Outperform Rating with $28 Target | RAPP Stock News
Citizens JMP pharmaceuticals analysts hold analyst/industry conference call